By Fineline Cube 
Shanghai-based medical device giant MicroPort Scientific Corp. (HKG: 0853), through its French subsidiary MicroPort Cardiac Rhythm Management (CRM), announced that its ALIZEA Hybrid Pacing System has received CE certification under the EU Medical Device Regulation. This system represents a significant advancement in MRI-conditional pacing technology.
System Innovation and Features
The ALIZEA Hybrid Pacing System, including ALIZEA, BOREA, and CELEA pacemakers, is designed to be used with MRI-compatible third-party pacing electrode leads. It forms a complete MRI-conditional safe pacing system and supports left bundle branch area pacing (LBBAP). This innovation marks a breakthrough in safety, adaptability, and innovation for pacing systems.-Fineline Info & Tech